Journal article
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
- Abstract:
-
UNLABELLED: Once-monthly (50/50, 100, and 150 mg) and daily (2.5 mg; 3-year vertebral fracture risk reduction: 52%) oral ibandronate regimens were compared in 1609 women with postmenopausal osteoporosis. At least equivalent efficacy and similar safety and tolerability were shown after 1 year. INTRODUCTION: Suboptimal adherence to daily and weekly oral bisphosphonates can potentially compromise therapeutic outcomes in postmenopausal osteoporosis. Although yet to be prospectively shown in oste...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
- Volume:
- 20
- Issue:
- 8
- Pages:
- 1315-1322
- Publication date:
- 2005-08-01
- DOI:
- EISSN:
-
1523-4681
- ISSN:
-
0884-0431
- Source identifiers:
-
126429
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:126429
- UUID:
-
uuid:84f5df77-1c41-49a8-aa05-96dca3edcf67
- Local pid:
- pubs:126429
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record